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Rationale: 
Particulate matter (PM) is a measurable component of air pollution that has been 
associated with adverse cardiovascular and respiratory outcomes.  Research indicates 
environmental factors such as air pollution are involved in changes through epigenetic 
mechanisms during development that may persist into adulthood and even span multiple 
generations of inheritance.  Epigenetics is the study of heritable changes of gene 
expression that do not alter the actual DNA sequence.  One epigenetic mechanism is DNA 
methylation.  Long Interspersed Nuclear Element (LINE-1) is a DNA repetitive element 
that can be used as a proxy measurement of DNA global methylation.  
The purpose of this pilot study was to compare epigenetic biomarkers across different 
sample matrices (i.e. blood and buccal) and across related subjects (i.e. maternal and 
infant).  
 
Methods: 
Informed consent was provided by pregnant women (n=23) who were recruited through 
Women, Infants, and Children (WIC), hospital birthing classes, or flyers in obstetrician’s 
offices.  Demographic and medical data was collected from hospital records for both 
mothers and newborns after birth.  Follow-up health surveys were administered by 
telephone that were designed to collect indicators of pre-asthmatic respiratory symptoms 
or conditions. 
 
Biological samples were collected before or shortly after time of birth at Community 
Medical Center of Missoula, MT.  The samples collected were maternal blood (n=15), 
umbilical cord blood (n=15), and maternal (n=23) and newborn (n=23) buccal (cheek) 
cells.  Buccal cells were collected and processed according to the Gentra Puregene Kit 
(Qiagen, Germantown, MD).  These biologically accessible tissues serve as surrogates to 
study gene methylation associated with respiratory health. 
 
Samples were stored at -80°C until DNA extraction and subsequent bisulfite treatment.   
The samples were amplified in duplicates with polymerase chain reaction (PCR).  LINE-1 
methylation was analyzed with pyrosequencing on a Pyromark Q96 MD (Qiagen, 
Germantown, MD).  All statistical analysis was performed in Statistical Analysis Software 
(SAS, version 9.3). 
 
Results: 
The mean (standard deviation (sd)) of LINE-1 methylation percentage for mother and 
infant buccal cell derived DNA were 58.75 (3.89) and 57.16 (2.54), respectively.  Percent 
methylation maximum for mother and infant buccal samples were 70.22 and 64.25, 
respectively, and minimum were 54.86 and 52.94, respectively.  Paired t-test indicated 
that LINE-1 methylation percentages in maternal buccal samples were higher than 
methylation percentages in the paired infant samples (mean difference (95%CL) = 4.4 
(2.3, 6.6)). 
 
The mean (sd) of LINE-1 methylation percentage for mother and infant/cord blood 
derived DNA were 75.19 (3.17) and 75.86 (3.05), respectively.  Percent methylation 
maximum for mother and infant blood samples were 79.42 and 79.50, respectively, and 
minimum were 70.39 and 69.31, respectively.  Paired t-test indicated that LINE-1 
methylation percentages in maternal blood samples were similar to methylation 
percentages in infant blood samples (mean difference (95% CL) = 0.66 (-2.0,3.3)). 
 
Conclusions: 
LINE-1 methylation percentages between sample matrices (i.e. blood and buccal) and 
subjects (i.e. maternal and infant) were not correlated.  The percent methylation of LINE-1 
in DNA from blood was consistently greater than for DNA from buccal tissue for both 
mother and newborn samples.  It was expected that LINE-1 measurements for blood DNA 
would differ from buccal DNA because circulating blood represents a more diverse cell 
population.  Gene-specific methylation of the promoter region for interferon-γ, a cytokine 
associated with asthma, will be studied with the remaining samples of bisulfite-treated 
DNA from this study.  Epigenetic changes may serve as useful biomarkers for predicting 
asthma risk in children exposed to biomass smoke.  These methods can be applied to 
future studies to investigate the epigenetic relationship of prenatal asthma risk and PM 
wood smoke exposure.   
 
 
